Sex differences in the treatment of Psoriatic Arthritis

A systematic literature review

Elena Generali, Carlo A. Scirè, Luca Cantarini, Carlo Selmi

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

Psoriatic arthritis (PsA) is a chronic inflammatory condition associated with skin psoriasis and manifests a wide clinical phenotype, with proposed differences between sexes. Current treatments are based on traditional disease-modifying antirheumatic drugs (DMARD), and biologic agents and studies have reported different clinical response patterns depending on sex factors. We aimed to identify sex differences in drug retention rate in patients with PsA and performed a systematic research on MEDLINE, EMBASE and Cochrane databases (1979 to June 2015) for studies regarding effectiveness (measured as drug retention rate) in PsA in both traditional DMARDs and biologics. Demographic data as well as retention rates between sexes were extracted. From a total 709 retrieved references, we included 9 articles for the final analysis. Only one study reported data regarding DMARDs, while eight studies reported retention rate for anti-tumor necrosis factor (TNF) biologics, mainly infliximab, adalimumab and etanercept. No differences were reported in retention rates between sexes for methotrexate, while women manifested lower retention rates compared to men with regard to anti-TNF. We highlight the need to include sex differences in the management flow chart of patients with PsA.

Original languageEnglish (US)
Pages (from-to)203-208
Number of pages6
JournalIsrael Medical Association Journal
Volume18
Issue number3-4
StatePublished - Mar 1 2016
Externally publishedYes

Fingerprint

Psoriatic Arthritis
Antirheumatic Agents
Sex Characteristics
Biological Products
Tumor Necrosis Factor-alpha
Sex Factors
Biological Factors
Therapeutics
Psoriasis
Methotrexate
MEDLINE
Pharmaceutical Preparations
Demography
Databases
Phenotype
Skin
Research

Keywords

  • Biologics
  • Drug retention rate
  • Gender medicine
  • Personalized medicine
  • Psoriasis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Generali, E., Scirè, C. A., Cantarini, L., & Selmi, C. (2016). Sex differences in the treatment of Psoriatic Arthritis: A systematic literature review. Israel Medical Association Journal, 18(3-4), 203-208.

Sex differences in the treatment of Psoriatic Arthritis : A systematic literature review. / Generali, Elena; Scirè, Carlo A.; Cantarini, Luca; Selmi, Carlo.

In: Israel Medical Association Journal, Vol. 18, No. 3-4, 01.03.2016, p. 203-208.

Research output: Contribution to journalReview article

Generali, E, Scirè, CA, Cantarini, L & Selmi, C 2016, 'Sex differences in the treatment of Psoriatic Arthritis: A systematic literature review', Israel Medical Association Journal, vol. 18, no. 3-4, pp. 203-208.
Generali, Elena ; Scirè, Carlo A. ; Cantarini, Luca ; Selmi, Carlo. / Sex differences in the treatment of Psoriatic Arthritis : A systematic literature review. In: Israel Medical Association Journal. 2016 ; Vol. 18, No. 3-4. pp. 203-208.
@article{e0072787b1c64d46ab28ce14d3e8a10a,
title = "Sex differences in the treatment of Psoriatic Arthritis: A systematic literature review",
abstract = "Psoriatic arthritis (PsA) is a chronic inflammatory condition associated with skin psoriasis and manifests a wide clinical phenotype, with proposed differences between sexes. Current treatments are based on traditional disease-modifying antirheumatic drugs (DMARD), and biologic agents and studies have reported different clinical response patterns depending on sex factors. We aimed to identify sex differences in drug retention rate in patients with PsA and performed a systematic research on MEDLINE, EMBASE and Cochrane databases (1979 to June 2015) for studies regarding effectiveness (measured as drug retention rate) in PsA in both traditional DMARDs and biologics. Demographic data as well as retention rates between sexes were extracted. From a total 709 retrieved references, we included 9 articles for the final analysis. Only one study reported data regarding DMARDs, while eight studies reported retention rate for anti-tumor necrosis factor (TNF) biologics, mainly infliximab, adalimumab and etanercept. No differences were reported in retention rates between sexes for methotrexate, while women manifested lower retention rates compared to men with regard to anti-TNF. We highlight the need to include sex differences in the management flow chart of patients with PsA.",
keywords = "Biologics, Drug retention rate, Gender medicine, Personalized medicine, Psoriasis",
author = "Elena Generali and Scir{\`e}, {Carlo A.} and Luca Cantarini and Carlo Selmi",
year = "2016",
month = "3",
day = "1",
language = "English (US)",
volume = "18",
pages = "203--208",
journal = "Israel Medical Association Journal",
issn = "1565-1088",
publisher = "Israel Medical Association",
number = "3-4",

}

TY - JOUR

T1 - Sex differences in the treatment of Psoriatic Arthritis

T2 - A systematic literature review

AU - Generali, Elena

AU - Scirè, Carlo A.

AU - Cantarini, Luca

AU - Selmi, Carlo

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Psoriatic arthritis (PsA) is a chronic inflammatory condition associated with skin psoriasis and manifests a wide clinical phenotype, with proposed differences between sexes. Current treatments are based on traditional disease-modifying antirheumatic drugs (DMARD), and biologic agents and studies have reported different clinical response patterns depending on sex factors. We aimed to identify sex differences in drug retention rate in patients with PsA and performed a systematic research on MEDLINE, EMBASE and Cochrane databases (1979 to June 2015) for studies regarding effectiveness (measured as drug retention rate) in PsA in both traditional DMARDs and biologics. Demographic data as well as retention rates between sexes were extracted. From a total 709 retrieved references, we included 9 articles for the final analysis. Only one study reported data regarding DMARDs, while eight studies reported retention rate for anti-tumor necrosis factor (TNF) biologics, mainly infliximab, adalimumab and etanercept. No differences were reported in retention rates between sexes for methotrexate, while women manifested lower retention rates compared to men with regard to anti-TNF. We highlight the need to include sex differences in the management flow chart of patients with PsA.

AB - Psoriatic arthritis (PsA) is a chronic inflammatory condition associated with skin psoriasis and manifests a wide clinical phenotype, with proposed differences between sexes. Current treatments are based on traditional disease-modifying antirheumatic drugs (DMARD), and biologic agents and studies have reported different clinical response patterns depending on sex factors. We aimed to identify sex differences in drug retention rate in patients with PsA and performed a systematic research on MEDLINE, EMBASE and Cochrane databases (1979 to June 2015) for studies regarding effectiveness (measured as drug retention rate) in PsA in both traditional DMARDs and biologics. Demographic data as well as retention rates between sexes were extracted. From a total 709 retrieved references, we included 9 articles for the final analysis. Only one study reported data regarding DMARDs, while eight studies reported retention rate for anti-tumor necrosis factor (TNF) biologics, mainly infliximab, adalimumab and etanercept. No differences were reported in retention rates between sexes for methotrexate, while women manifested lower retention rates compared to men with regard to anti-TNF. We highlight the need to include sex differences in the management flow chart of patients with PsA.

KW - Biologics

KW - Drug retention rate

KW - Gender medicine

KW - Personalized medicine

KW - Psoriasis

UR - http://www.scopus.com/inward/record.url?scp=84963727736&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84963727736&partnerID=8YFLogxK

M3 - Review article

VL - 18

SP - 203

EP - 208

JO - Israel Medical Association Journal

JF - Israel Medical Association Journal

SN - 1565-1088

IS - 3-4

ER -